Cargando…
The role of transplantation in Hodgkin lymphoma
Despite the success of frontline anthracycline-based chemotherapy for classical Hodgkin Lymphoma (cHL), approximately 15% of patients do not achieve an adequate response and require further therapy. For transplant-eligible patients, additional treatment followed by high-dose chemotherapy and autolog...
Autores principales: | Maranzano, Michael, Mead, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908991/ https://www.ncbi.nlm.nih.gov/pubmed/36776370 http://dx.doi.org/10.3389/fonc.2022.1054314 |
Ejemplares similares
-
Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023) -
Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013) -
Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
por: Renner, Christoph, et al.
Publicado: (2018) -
Advances in Hodgkin Lymphoma: Including the Patient’s Voice
por: Smith, Christine Moore, et al.
Publicado: (2022) -
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma
por: Ferrarini, Isacco, et al.
Publicado: (2023)